[go: up one dir, main page]

KR950005921A - 상처 치료를 촉진시키기 위한 조성물 - Google Patents

상처 치료를 촉진시키기 위한 조성물 Download PDF

Info

Publication number
KR950005921A
KR950005921A KR1019930016390A KR930016390A KR950005921A KR 950005921 A KR950005921 A KR 950005921A KR 1019930016390 A KR1019930016390 A KR 1019930016390A KR 930016390 A KR930016390 A KR 930016390A KR 950005921 A KR950005921 A KR 950005921A
Authority
KR
South Korea
Prior art keywords
group
composition
wound treatment
promoting
triazol
Prior art date
Application number
KR1019930016390A
Other languages
English (en)
Other versions
KR100242479B1 (ko
Inventor
아키라 세오
구니카즈 히라가
히로야스 고가
요시미 니와노
Original Assignee
무라다 도시카즈
니혼노야쿠 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 무라다 도시카즈, 니혼노야쿠 가부시키가이샤 filed Critical 무라다 도시카즈
Priority to KR1019930016390A priority Critical patent/KR100242479B1/ko
Publication of KR950005921A publication Critical patent/KR950005921A/ko
Application granted granted Critical
Publication of KR100242479B1 publication Critical patent/KR100242479B1/ko

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41961,2,4-Triazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

일반식(Ⅰ)의 화합물을 활성성분으로서 포함하는 상처 치료를 촉진시키기 위한 조성물에 대해 기술하였다.
상기식에서, R은 수소원자, 페닐 그룹 또는, 할로겐 원자, C1-C6알킬그룹, 하이드록실 그룹 또는 C1-C6알콕시 그룹에 의해 치환된 페닐 그룹이고, X는 1-이미다졸릴 그룹 또는 1,2,4-트리아졸-1-일 그룹이다.

Description

상처 치료를 촉진시키기 위한 조성물
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (6)

  1. 활성 성분으로서의 일반식(Ⅰ)의 화합물 및 약제학적으로 허용되는 담체를 포함함을 특징으로 하는, 상처 치료를 촉진시키기 위한 조성물.
    상기식에서, R은 수소원자, 페닐 그룹 또는, 할로겐 원자, C1-C6알킬그룹, 하이드록실 그룹 또는 C1-C6알콕시 그룹에 의해 치환된 페닐 그룹이고, X는 1-이미다졸릴 그룹 또는 1,2,4-트리아졸-1-일 그룹이다.
  2. 제1항에 있어서, R이 o-클로로페닐 그룹, p-하이드록시 페닐 그룹 또는 p-톨릴 그룹인 조성물.
  3. 제1항 또는 제2항에 있어서, 국소용으로 사용하기 위한 조성물.
  4. 제1항 또는 제2항의 상처 치료를 촉진시키기 위한 조성물을, 상처 치료를 촉진시킬 필요가 있는 환자에게 투여함을 특징으로 하여, 상처 치료를 촉진시키는 방법.
  5. 제4항에 있어서, 조성물을 상처에 국소 투여하는 방법.
  6. 일반식(Ⅰ′)의 화합물.
    상기식에서, X는 1-이미다졸릴 그룹 또는 1,2,4-트리아졸-1-일 그룹이다.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019930016390A 1993-08-24 1993-08-24 상처 치료를 촉진시키기 위한 조성물 KR100242479B1 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019930016390A KR100242479B1 (ko) 1993-08-24 1993-08-24 상처 치료를 촉진시키기 위한 조성물

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019930016390A KR100242479B1 (ko) 1993-08-24 1993-08-24 상처 치료를 촉진시키기 위한 조성물

Publications (2)

Publication Number Publication Date
KR950005921A true KR950005921A (ko) 1995-03-20
KR100242479B1 KR100242479B1 (ko) 2000-03-02

Family

ID=19361779

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019930016390A KR100242479B1 (ko) 1993-08-24 1993-08-24 상처 치료를 촉진시키기 위한 조성물

Country Status (1)

Country Link
KR (1) KR100242479B1 (ko)

Also Published As

Publication number Publication date
KR100242479B1 (ko) 2000-03-02

Similar Documents

Publication Publication Date Title
KR950016732A (ko) 피부 및 질의 위축 억제방법
AU3380997A (en) Substituted imidazoles having cytokine inhibitory activity
KR950010890A (ko) 폐경기 증후군의 치료방법
DE69637948D1 (de) Substituierte imidazole mit krebsremmender und cytokininhibierender wirkung
KR910011896A (ko) 신규한 글리코펩티드 유도체
KR970074765A (ko) 비타민 d₃ 동족체
KR950016725A (ko) 폐 고혈압성 질병을 억제하는 방법
KR950031060A (ko) 골다공증 치료용 약제학적 조성물
ES2104090T3 (es) Nuevas 3',5'-di-t-butil-4'-hidroxi-flavonas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
KR950016724A (ko) 폐경기 후 여성의 리비도를 증가시키는 방법
KR920002579A (ko) 종양치료 조성물 및 치료방법
KR970707108A (ko) 항염증제로 유용한, 복소환부를 갖는 디-t-부틸페놀 화합물(DI-TERT-BUTYLPHENOL COMPOUNDS WITH HETEROCYCLIC MOIETY, USEFUL AS ANTI-INFLAMMATORY AGENTS)
KR890011596A (ko) 불면증 치료용 의약품의 제조에 있어서 1,4-이치환-피페리디닐 화합물의 용도
KR950016742A (ko) 폐경후 여성의 씨엔에스 질환을 억제하는 방법
KR950016760A (ko) 치질 치료제
KR970061246A (ko) 테스토스테론을 증가시키기 위한 약학 조성물
DK0608308T3 (da) Anti-seboréformulering
KR950016734A (ko) 성적 조숙증의 억제방법
RU94045271A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования синдрома тернера
KR930012036A (ko) 골 흡수 억제용 약제학적 조성물
RU95106653A (ru) Производные 2-имидазолин-5-онов и 2-имидазолин-5-тионов и фунгицидные композиции на их основе
RS50033B (sr) Derivati etansulfonil-piperidina
KR950005921A (ko) 상처 치료를 촉진시키기 위한 조성물
MX9206930A (es) Nuevos compuestos
KR950016728A (ko) 여성에서 다모증 및 탈모증을 억제하는 방법

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19930824

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19970830

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19930824

Comment text: Patent Application

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 19990820

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 19991110

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 19991111

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20021015

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20031106

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20041025

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 20051025

Start annual number: 7

End annual number: 7

FPAY Annual fee payment

Payment date: 20061026

Year of fee payment: 8

PR1001 Payment of annual fee

Payment date: 20061026

Start annual number: 8

End annual number: 8

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

Termination category: Default of registration fee

Termination date: 20081010